Integrating ultrasound and serum indicators for evaluating outcomes of targeted immunotherapy in advanced liver cancer

Figure 7 Net reduction graphs for Target Immunotherapy Predictive Model across various groups. A: Net reduction (NR) curve for the Target Immunotherapy Predictive Model (TIPM) in the internal training cohort; B: NR curve for TIPM in the internal validation cohort; C: NR curve for TIPM in the external validation cohort. The graphs show that TIPM consistently achieves a greater net reduction, emphasizing its ability to minimize unnecessary interventions across all groups. TIPM: Target Immunotherapy Predictive Model.